As spring blooms in May, weed pollen peaks—triggering allergies for millions. Explore the science behind this reaction and ...

Rapt Therapeutics has conducted its second round of layoffs in just under a year, continuing a period of upheaval following ...

Clear Street initiated coverage of Rapt Therapeutics with a Buy rating and set a $3 price target, as the research firm has ...

IgE-mediated allergy: An immune response in which immunoglobulin E antibodies trigger the release of inflammatory mediators following exposure to an allergen. Type I hypersensitivity: Immediate ...

IgE-mediated: Describes allergic reactions involving immunoglobulin E antibodies, which lead to mast cell degranulation and the release of inflammatory mediators.

Novartis’ anti-IgE antibody Xolair (omalizumab) has been a mainstay of treatment for refractory CSU for many years. However, the drug is heading for patent expiry in Europe this year and in the ...

Yet my experience is a blip among the millions of people with allergies in Australia. Around 5 million Australians live with ...

In an update on its respiratory pipeline this morning, Sanofi said that anti-OX40L antibody amlitelimab ... asthma is characterised by high immunoglobulin E, hyper-reactive airways, and poor ...

which are caused by immunoglobulin E antibodies’ reaction with food. This reaction leads to histamine or other allergic substances being released. IgE-mediated food allergies can be serious or ...

Test your allergy knowledge with a quiz to recognize symptoms, avoid triggers, and manage flare-ups effectively.

The latter occurs most notably in the neonate as a result of a mother with antibodies due to AITD. TPO antibodies (TPOAb) appear involved in the tissue destructive processes associated with the ...